Royal Harbor Partners, LLC Eli Lilly & CO Transaction History

Royal Harbor Partners, LLC

$188 Million
Q3 2024

A detailed history of Royal Harbor Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Royal Harbor Partners, LLC holds 530 shares of LLY stock, worth $406,912. This represents 0.25% of its overall portfolio holdings.

Number of Shares

530

Previous 530 -0.0%

Holding current value

$406,912

Previous $479,000 2.09%

% of portfolio

0.25%

Previous 0.24%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$724.87 - $909.04 $384,181 - $481,791	530 New	530 $479,000
Q1 2023 Apr 21, 2023	SELL	$310.63 - $364.82 $1.16 Million - $1.36 Million	-3,736 Reduced 80.8%	888 $304,000
Q4 2022 Jan 23, 2023	SELL	$321.55 - $374.67 $122,510 - $142,749	-381 Reduced 7.61%	4,624 $0
Q3 2022 Oct 21, 2022	SELL	$296.48 - $337.87 $422,780 - $481,802	-1,426 Reduced 22.17%	5,005 $1.62 Million
Q2 2022 Aug 05, 2022	BUY	$278.73 - $327.27 $14,493 - $17,018	52 Added 0.82%	6,431 $2.09 Million
Q1 2022 Aug 05, 2022	SELL	$234.69 - $291.66 $51,397 - $63,873	-219 Reduced 3.32%	6,379 $1.83 Million
Q4 2021 Feb 02, 2022	BUY	$224.85 - $279.04 $43,171 - $53,575	192 Added 3.0%	6,598 $1.82 Million
Q3 2021 Oct 19, 2021	SELL	$221.6 - $272.71 $173,734 - $213,804	-784 Reduced 10.9%	6,406 $1.48 Million
Q2 2021 Jul 16, 2021	SELL	$180.55 - $233.54 $104,357 - $134,986	-578 Reduced 7.44%	7,190 $1.65 Million
Q1 2021 Apr 12, 2021	SELL	$164.32 - $212.72 $68,192 - $88,278	-415 Reduced 5.07%	7,768 $1.45 Million
Q4 2020 Jan 25, 2021	BUY	$130.46 - $172.63 $276,183 - $365,457	2,117 Added 34.9%	8,183 $1.38 Million
Q3 2020 Oct 08, 2020	BUY	$146.22 - $169.13 $20,617 - $23,847	141 Added 2.38%	6,066 $898,000
Q2 2020 Aug 10, 2020	BUY	$136.42 - $164.18 $808,288 - $972,766	5,925 New	5,925 $973,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Harbor Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Royal Harbor Partners, LLC with notifications on news.

Account

Royal Harbor Partners, LLC Eli Lilly & CO Transaction History